Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CLVT logo CLVT
Upturn stock ratingUpturn stock rating
CLVT logo

CLARIVATE PLC (CLVT)

Upturn stock ratingUpturn stock rating
$4.31
Last Close (24-hour delay)
Profit since last BUY-3.79%
upturn advisory
Consider higher Upturn Star rating
BUY since 2 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/28/2025: CLVT (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

10 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $5.14

1 Year Target Price $5.14

Analysts Price Target For last 52 week
$5.14 Target price
52w Low $3.04
Current$4.31
52w High $7.15

Analysis of Past Performance

Type Stock
Historic Profit -59.61%
Avg. Invested days 35
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/28/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.90B USD
Price to earnings Ratio -
1Y Target Price 5.14
Price to earnings Ratio -
1Y Target Price 5.14
Volume (30-day avg) 10
Beta 1.4
52 Weeks Range 3.04 - 7.15
Updated Date 08/28/2025
52 Weeks Range 3.04 - 7.15
Updated Date 08/28/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.61

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-07-30
When -
Estimate 0.17
Actual -0.11

Profitability

Profit Margin -17.33%
Operating Margin (TTM) 9.17%

Management Effectiveness

Return on Assets (TTM) 1.16%
Return on Equity (TTM) -8.18%

Valuation

Trailing PE -
Forward PE 6.79
Enterprise Value 7245941406
Price to Sales(TTM) 1.16
Enterprise Value 7245941406
Price to Sales(TTM) 1.16
Enterprise Value to Revenue 2.9
Enterprise Value to EBITDA 10.58
Shares Outstanding 672219008
Shares Floating 398800682
Shares Outstanding 672219008
Shares Floating 398800682
Percent Insiders 16.66
Percent Institutions 89.99

ai summary icon Upturn AI SWOT

CLARIVATE PLC

stock logo

Company Overview

overview logo History and Background

Clarivate was formed in 2016 after being spun off from Thomson Reuters' Intellectual Property & Science business. It provides data and analytics to accelerate the pace of innovation.

business area logo Core Business Areas

  • Science: Provides information and workflow solutions for scientific research, including journals, citation indexes, and research analytics.
  • Intellectual Property: Offers intellectual property management, data, and analytics solutions for patents, trademarks, and domains.
  • Life Sciences & Healthcare: Provides data, analytics, and insights to support drug development, commercialization, and healthcare decision-making.

leadership logo Leadership and Structure

The leadership team includes Jonathan Gear as CEO. The company operates with a functional organizational structure across its business segments.

Top Products and Market Share

overview logo Key Offerings

  • Web of Science: A leading citation database providing comprehensive coverage of scholarly literature. Competitors: Scopus (Elsevier), Google Scholar. Market Share estimates vary across specific research fields, but Web of Science is a dominant player.
  • Derwent Innovation: A patent database offering enhanced patent information and analysis tools. Competitors: LexisNexis, Questel. Market Share in patent data and analytics is significant, with high revenue generation.
  • Cortellis: A suite of life science intelligence solutions covering drug development. Competitors: IQVIA, Veeva Systems. Revenue from this product is significant and has many users.

Market Dynamics

industry overview logo Industry Overview

The market for research, intellectual property, and life sciences information is growing, driven by increasing R&D spending and the need for data-driven insights. Focus is shifting to AI-driven platforms.

Positioning

Clarivate is a key player in the industry, providing data, analytics, and workflow solutions. Its competitive advantage lies in its comprehensive data assets and trusted brands.

Total Addressable Market (TAM)

The TAM is estimated to be several billions of dollars annually, including research analytics, IP intelligence, and life science data. Clarivate is well-positioned to capture a significant share.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition
  • Comprehensive data assets
  • Global presence
  • Diverse product portfolio
  • High renewal rates

Weaknesses

  • High debt level
  • Integration challenges from acquisitions
  • Dependence on subscriptions
  • Complexity of product offerings
  • Potential exposure to open access initiatives

Opportunities

  • Expanding into new geographic markets
  • Developing new AI-powered products
  • Acquiring complementary businesses
  • Increasing penetration in existing markets
  • Leveraging data analytics for new insights

Threats

  • Competition from established players and new entrants
  • Economic downturn affecting R&D spending
  • Changing regulatory landscape
  • Data privacy concerns
  • Disruptive technologies

Competitors and Market Share

competitor logo Key Competitors

  • RELX (RELX)
  • Wolters Kluwer (WOLK)
  • IQVIA (IQV)

Competitive Landscape

Clarivate competes on data quality, product functionality, and customer service. RELX is a larger competitor with a broader portfolio, while IQVIA focuses on the life sciences market. Wolters Kluwer offers information and software solutions for professionals.

Major Acquisitions

ProQuest

  • Year: 2021
  • Acquisition Price (USD millions): 5300
  • Strategic Rationale: Expanded Clarivate's content offerings and strengthened its position in the academic research market.

Growth Trajectory and Initiatives

Historical Growth: Growth has been driven by acquisitions and organic revenue growth in key segments.

Future Projections: Analyst projections vary, but generally anticipate continued growth driven by demand for data and analytics.

Recent Initiatives: Recent initiatives include new product launches and strategic acquisitions to expand its product portfolio.

Summary

Clarivate is a significant player in the research and IP information space, benefiting from strong brands and comprehensive data. While it has a high debt load from acquisitions, it's positioned for growth through innovation and expansion into new markets. Competition and economic conditions pose ongoing challenges.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings (10-K, 10-Q)
  • Industry reports
  • Analyst estimates
  • Press releases

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market share figures are estimates and may vary. Actual results may differ from projections.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About CLARIVATE PLC

Exchange NYSE
Headquaters -
IPO Launch date 2018-10-29
CEO & Director Mr. Matitiahu Shem Tov
Sector Technology
Industry Information Technology Services
Full time employees 12000
Full time employees 12000

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.